Unixell
1 known investors
Unixell Biotechnology develops next-generation cell therapies based on human pluripotent stem cells, with a pipeline focused on major neurodegenerative diseases. Founded in 2021, the company has built technology platforms including reprogramming, stem cell differentiation, SISBAR lineage tracing, and high-precision gene editing.
Investors · 1
Frequently asked questions
- What does Unixell do?
- Unixell Biotechnology develops next-generation cell therapies based on human pluripotent stem cells, with a pipeline focused on major neurodegenerative diseases. Founded in 2021, the company has built technology platforms including reprogramming, stem cell differentiation, SISBAR lineage tracing, and high-precision gene editing.
- Who are Unixell's investors?
- Unixell's investors include Pan-Lin Capital.